Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT07792642
Starting soon Not applicable

FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease

NCT07792642 · tracked via the Priya Life Science Portugal tracker
Phase
Not applicable
Started
2026-09-01
Last updated
2026-09-01

Condition(s) studied

Chronic Obstructive Pulmonary Disease (COPD)

Investigational drug(s) / intervention(s)

Pulmonary rehabilitation programmePulmonary rehabilitation programme

Pulmonary rehabilitation programme: Participants will undergo a supervised, in-person pulmonary rehabilitation programme lasting for twelve weeks, twice a week. The intervention comprises cardiorespiratory exercise training, conducted on either a treadmill or a cycle ergometer. Exercise intensity will be individually prescribed based on the power output registered at the first metabolic threshold, during a baseline cardiopulmonary exercise test. For treadmill exercise prescription, guideline-based estimation equations will be used to estimate treadmill velocity based on the oxygen uptake obtained in the first metabolic threshold. Resistance training will be provided in the same sessions as internationally recommended. Progress will occur on weekly basis, according to symptoms. Education and psychosocial support will also be provided once every other week. All sessions will range from 60-90 minutes.

Pulmonary rehabilitation programme: Standard of care (pulmonary rehabilitation programme featuring six-minute walking test-derived cardiorespiratory exercise prescription).

Study summary

This randomised controlled trial aims to: i) compare the power output at the first metabolic threshold (WMT1) between the MT1 and the six-minute walking test (6MWT)-based cardiorespiratory exercise prescriptions in chronic obstructive pulmonary disease (COPD); ii) compare exercise adherence, peripheral muscle strength, health-related quality of life, dyspnoea, fatigue, disease impact and emotional status between MT1 and 6MWT-based exercise prescriptions.

Patients will be recruited via the pulmonology services from Unidade Local de Saúde do Baixo Mondego and Unidade Local de Saúde de Aveiro.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of COPD; * Complete a maximal CPET with MT1 identification. Exclusion Criteria: * Presence of unstable or significant conditions (e.g. musculoskeletal, neurological, cardiovascular, neoplasia or immunological) that renders the participation in the pulmonary rehabilitation program infeasible; * Participated in pulmonary rehabilitation in the last 12 months.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Aveiro Aveiro Portugal

More Aveiro University trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07792642 on ClinicalTrials.gov ↗ ← All trials in Portugal